Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04270812 · ClinicalTrials.gov registry record · NA

Treating Sleep in Teens With ADHD

A NA study of Sleep and ADHD, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT04270812: Completed NA study of Sleep and ADHD, sponsored by Children's Hospital Medical Center, Cincinnati.

NCT04270812 is a NA study of Sleep and ADHD that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 14 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04270812, a NA study of Sleep and ADHD, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

Sleep problems are common in adolescence and recognized as an international public health concern given their links to a range of adverse outcomes. Adolescents with attention-deficit/hyperactivity disorder (ADHD) experience more sleep problems than their peers, including delayed sleep onset, shorter sleep duration, poorer sleep quality, more sleep variability, and greater daytime sleepiness. Further, research conducted by the investigator's team has shown that sleep problems are strongly associated with - and causal contributors to - functional impairment in adolescents with ADHD, including increased mood, behavior, and academic problems. However, sleep problems are not currently addressed in any evidence-based treatment for adolescents with ADHD, and no study has evaluated an intervention targeting sleep problems in adolescents with ADHD. This is a notable gap in the field since consensus statements on sleep suggest that treating sleep problems may improve ADHD and associated impairments. Evidence-based cognitive-behavioral sleep interventions, including the Transdiagnostic Sleep and Circadian Intervention for Youth (TranS-C) intervention, are effective for improving sleep and associated impairments (e.g., attention, mood) in adolescents with sleep problems. However, these interventions have never been tested in adolescents with ADHD specifically. This will be the first to evaluate a cognitive-behavioral sleep intervention (TranS-C) in adolescents with ADHD who experience co-occurring sleep problems. This study will recruit 15 adolescents with ADHD and sleep problems to enroll in and complete an open trial of the TranS-C intervention to evaluate its feasibility, acceptability, and preliminary efficacy. Findings will provide key pilot data regarding treatment of sleep problems in adolescents with ADHD.

Primary Outcome

Overall sleep quality measured used the adolescent-completed Pittsburgh Sleep Quality Index (PSQI)

Conditions Studied

Interventions

  • BEHAVIORAL Transdiagnostic Sleep and Circadian Intervention for Youth (TranS-C)

Study Locations (1)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2018-10-16
Est. Completion 2020-10-31
Phase NA

What the finished NCT04270812 record still lists

NCT04270812 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Sleep appearing as the primary indexed condition, and to 1 intervention - of which Transdiagnostic Sleep and Circadian Intervention for Youth (TranS-C) is the first listed.

NCT04270812 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04270812 about?

NCT04270812 is a clinical study titled "Treating Sleep in Teens With ADHD". Sleep problems are common in adolescence and recognized as an international public health concern given their links to a range of adverse outcomes. Adolescents with attention-deficit/hyperactivity disorder (ADHD) experience more sleep problems than their peers, including delayed sleep onset, shorter...

What is the current status of trial NCT04270812?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2018-10-16. Estimated completion is 2020-10-31.

What conditions does trial NCT04270812 study?

This clinical trial studies the following conditions: Sleep, ADHD.

What interventions are being tested in trial NCT04270812?

The interventions under investigation include: Transdiagnostic Sleep and Circadian Intervention for Youth (TranS-C) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04270812?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04270812 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04270812's enrollment target sits among peer trials

14 145th of 151 higher than 7 of 151 other Sleep trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT04270812, the US trial registry maintained by the National Library of Medicine. NCT04270812 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.